Management of adult patients with severe atopic dermatitis treated with dupilumab during COVID-19 pandemic: A single-center real-life experience

Dermatol Ther. 2020 Jul;33(4):e13765. doi: 10.1111/dth.13765. Epub 2020 Jun 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / epidemiology*
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / epidemiology
  • Female
  • Humans
  • Interleukin-4 Receptor alpha Subunit
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Pandemics*
  • Pneumonia, Viral / epidemiology*
  • SARS-CoV-2
  • Severity of Illness Index
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • Interleukin-4 Receptor alpha Subunit
  • dupilumab